CELLECTAR BIOSCIENCES INC's ticker is CLRB and the CUSIP is 15117F500. A total of 17 filers reported holding CELLECTAR BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $67,000 | -23.0% | 166,500 | +31.3% | 0.00% | – |
Q1 2022 | $87,000 | +8.8% | 126,800 | +5.7% | 0.00% | – |
Q4 2021 | $80,000 | -80.7% | 119,931 | -73.2% | 0.00% | -100.0% |
Q3 2021 | $414,000 | -65.6% | 447,074 | -55.8% | 0.00% | -50.0% |
Q2 2021 | $1,203,000 | -16.3% | 1,011,268 | +13.3% | 0.00% | 0.0% |
Q1 2021 | $1,437,000 | +155.2% | 892,557 | +229.5% | 0.00% | +100.0% |
Q4 2020 | $563,000 | +2.9% | 270,865 | -38.6% | 0.00% | 0.0% |
Q3 2020 | $547,000 | -45.9% | 441,327 | -44.2% | 0.00% | 0.0% |
Q2 2020 | $1,012,000 | +227.5% | 790,602 | +240.6% | 0.00% | – |
Q1 2020 | $309,000 | -31.0% | 232,102 | +16.6% | 0.00% | – |
Q4 2019 | $448,000 | +26.6% | 199,002 | +12.5% | 0.00% | – |
Q3 2019 | $354,000 | +32.1% | 176,902 | +43.8% | 0.00% | – |
Q2 2019 | $268,000 | +101.5% | 123,048 | +116.8% | 0.00% | – |
Q1 2019 | $133,000 | +51.1% | 56,748 | -0.5% | 0.00% | – |
Q4 2018 | $88,000 | -50.0% | 57,048 | -2.6% | 0.00% | – |
Q3 2018 | $176,000 | – | 58,553 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 1,772,848 | $3,688,000 | 2.14% |
Sio Capital Management, LLC | 2,331,123 | $4,849,000 | 0.99% |
Consonance Capital Management LP | 4,074,074 | $8,474,000 | 0.79% |
Altium Capital Management LP | 851,852 | $1,772,000 | 0.66% |
Tri Locum Partners LP | 658,373 | $1,369,000 | 0.50% |
Maven Securities LTD | 1,725,000 | $3,709,000 | 0.37% |
SABBY MANAGEMENT, LLC | 499,030 | $1,038,000 | 0.20% |
FNY Investment Advisers, LLC | 220,321 | $458,000 | 0.12% |
683 Capital Management, LLC | 925,925 | $1,926,000 | 0.09% |
Boxer Capital, LLC | 920,000 | $1,914,000 | 0.06% |